 | Up a level |
Wykoff, Charles C; Garweg, Justus G; Regillo, Carl; Souied, Eric; Wolf, Sebastian; Dhoot, Dilsher S; Agostini, Hansjuergen T; Chang, Andrew; Laude, Augustinus; Wachtlin, Joachim; Kovacic, Lidija; Wang, Lixin; Wang, Ying; Bouillaud, Emmanuel; Brown, David M (2024). KESTREL and KITE Phase 3 studies: 100-week results with brolucizumab in patients with diabetic macular edema. American journal of ophthalmology, 260, pp. 70-83. Elsevier Science 10.1016/j.ajo.2023.07.012
Brown, David M; Emanuelli, Andrés; Bandello, Francesco; Barranco, Jose Juan Escobar; Figueira, João; Souied, Eric; Wolf, Sebastian; Gupta, Vishali; Ngah, Nor Fariza; Liew, Gerald; Tuli, Raman; Tadayoni, Ramin; Dhoot, Dilsher; Wang, Lixin; Bouillaud, Emmanuel; Wang, Ying; Kovacic, Lidija; Guerard, Nicolas; Garweg, Justus (2022). KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema. American journal of ophthalmology, 238, pp. 157-172. Elsevier 10.1016/j.ajo.2022.01.004
